Skip to main content
. 1998 Mar;72(3):2406–2415. doi: 10.1128/jvi.72.3.2406-2415.1998

FIG. 1.

FIG. 1

Diagrammatic representation of the envelope of FIV. Sites of proteolytic cleavage eliminating an amino-terminal signal peptide (arrowhead) and generating mature surface (SU) and transmembrane (TM) envelope glycoproteins (arrow) are indicated. Peptides SU2, SU5, and TM3 were used as immunogens. Positions correspond to the amino acid sequence of the envelope glycoprotein of the Wo strain. Symbols: ▪, peptides; Inline graphic, signal sequence; Created by potrace 1.16, written by Peter Selinger 2001-2019 , putative membrane-spanning domain.

HHS Vulnerability Disclosure